1. Radu AF, Bungau SG (2021): Management of rheumatoid arthritis: an overview. Cells 10: 2857.
2.
Liu J, Gao J, Niu Q, et al. (2022): Bibliometric and visualization analysis of mesenchymal stem cells and rheumatoid arthritis (from 2012 to 2021). Front Immunol 13: 1001598.
3.
Karimzadeh H, Seyedbonakdar Z, Mousavi M, et al. (2016): Comparison the percentage of detection of periarthritis in patients with rheumatoid arthritis using clinical examination or ultrasound methods. J Res Med Sci 21: 134.
4.
Ortíz-Fernández L, Martín J, Alarcón-Riquelme ME (2023): A summary on the genetics of systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, and Sjögren’s syndrome. Clin Rev Allergy Immunol 64: 392-411.
5.
Aiewruengsurat D, Phongnarudech T, Liabsuetrakul T, et al. (2023): Correlation of rheumatoid and cardiac biomarkers with cardiac anatomy and function in rheumatoid arthritis patients without clinically overt cardiovascular diseases: A cross-sectional study. Int J Cardiol Heart Vasc 44: 101161.
6.
Yazdanifar MA, Bagherzadeh-Fard M, Habibi MA, et al. (2023): The association between thyroid dysfunction, autoimmune thyroid disease, and rheumatoid arthritis disease severity. BMC Endocr Disord 23: 212.
7.
Paschou SA, Bletsa E, Stampouloglou PK, et al. (2022): Thyroid disorders and cardiovascular manifestations: an update. Endocrine 75: 672-683.
8.
Vargas-Uricoechea H (2023): Molecular mechanisms in autoimmune thyroid disease. Cells 12: 918.
9.
Li Q, Wang B, Mu K, et al. (2018): Increased risk of thyroid dysfunction among patients with rheumatoid arthritis. Front Endocrinol (Lausanne) 9: 799.
10.
Nazary K, Hussain N, Ojo RO, et al. (2021): Prevalence of thyroid dysfunction in newly diagnosed rheumatoid arthritis patients. Cureus 13: e18204.
11.
Liu YJ, Miao HB, Lin S, et al. (2022): Association between rheumatoid arthritis and thyroid dysfunction: A meta-analysis and systematic review. Front Endocrinol (Lausanne) 13: 1015516.
12.
Kay J, Upchurch KS (2012): ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford) 51 Suppl. 6: vi5-vi9.
13.
Liang HY, Yin HX, Li SF, et al. (2022): Calcium-permeable channels cooperation for rheumatoid arthritis: therapeutic opportunities. Biomolecules 12: 1383.
14.
Bagherzadeh-Fard M, Yazdanifar MA, Aghaali M, et al. (2022): The prevalence of thyroid dysfunction and autoimmune thyroid disease in patients with rheumatoid arthritis. BMC Rheumatol 6: 63.
15.
Laurberg P, Cerqueira C, Ovesen L, et al. (2010): Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab 24: 13-27.
16.
Aakre I, Tveito Evensen L, Kjellevold M, et al. (2020): Iodine status and thyroid function in a group of seaweed consumers in Norway. Nutrients 12: 3483.
17.
Wright JJ, Powers AC, Johnson DB (2021): Endocrine toxicities of immune checkpoint inhibitors. Nat Rev Endocrinol 17: 389-399.
18.
Cárdenas Roldán J, Amaya-Amaya J, Castellanos-de la Hoz J, et al. (2012): Autoimmune thyroid disease in rheumatoid arthritis: a global perspective. Arthritis 2012: 864907.
19.
Lei Y, Yang J, Li H, et al. (2019): Changes in glucose-lipid metabolism, insulin resistance, and inflammatory factors in patients with autoimmune thyroid disease. J Clin Lab Anal 33: e22929.
20.
Tan M, Korkmaz H, Aydın H, et al. (2019): FABP4 levels in hypothyroidism and its relationship with subclinical atherosclerosis. Turk J Med Sci 49: 1490-1497.
21.
Nikiphorou E, de Lusignan S, Mallen C, et al. (2020): Haematological abnormalities in new-onset rheumatoid arthritis and risk of common infections: a population-based study. Rheumatology (Oxford) 59: 997-1005.
22.
Sun Y, Kan X, Zheng R, et al. (2023): Hashimoto’s thyroiditis, vitiligo, anemia, pituitary hyperplasia, and lupus nephritis – A case report of autoimmune polyglandular syndrome type III C + D and literature review. Front Pediatr 11: 1062505.
23.
Khalid S, Asad-Ur-Rahman F, Abbass A, et al. (2016): Myxedema ascites: A rare presentation of uncontrolled hypothyroidism. Cureus 8: e912.
